181 related articles for article (PubMed ID: 1827344)
41. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients.
Jacyk WK; Mpofu P
Cutis; 2001 Oct; 68(4 Suppl):48-54. PubMed ID: 11845948
[TBL] [Abstract][Full Text] [Related]
42. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
[TBL] [Abstract][Full Text] [Related]
43. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
[TBL] [Abstract][Full Text] [Related]
44. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
[TBL] [Abstract][Full Text] [Related]
45. Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
Leyden J; Wortzman M; Baldwin EK
J Drugs Dermatol; 2009 Apr; 8(4):383-8. PubMed ID: 19363857
[TBL] [Abstract][Full Text] [Related]
46. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
47. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
Leyden JJ; Tanghetti EA; Miller B; Ung M; Berson D; Lee J
Cutis; 2002 Feb; 69(2 Suppl):12-9. PubMed ID: 12095064
[TBL] [Abstract][Full Text] [Related]
48. Adapalene for acne.
Med Lett Drugs Ther; 1997 Feb; 39(995):19-20. PubMed ID: 9057779
[No Abstract] [Full Text] [Related]
49. Adapalene: a review of its use in the treatment of acne vulgaris.
Waugh J; Noble S; Scott LJ
Drugs; 2004; 64(13):1465-78. PubMed ID: 15212561
[TBL] [Abstract][Full Text] [Related]
50. Treatment of 2,453 acne vulgaris patients aged 12-17 years with the fixed-dose adapalene-benzoyl peroxide combination topical gel: efficacy and safety.
Eichenfield LE; Jorizzo JL; Dirschka T; Taub AF; Lynde C; Graeber M; Kerrouche N
J Drugs Dermatol; 2010 Nov; 9(11):1395-401. PubMed ID: 21061762
[TBL] [Abstract][Full Text] [Related]
51. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study.
Kawashima M; Harada S; Loesche C; Miyachi Y
J Dermatol Sci; 2008 Mar; 49(3):241-8. PubMed ID: 18063345
[TBL] [Abstract][Full Text] [Related]
52. Topical treatment of acne vulgaris: retinoids and cutaneous irritation.
Leyden JJ
J Am Acad Dermatol; 1998 Apr; 38(4):S1-4. PubMed ID: 9555819
[No Abstract] [Full Text] [Related]
53. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Goreshi R; Samrao A; Ehst BD
J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
[TBL] [Abstract][Full Text] [Related]
54. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
Guerra-Tapia A
J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
[TBL] [Abstract][Full Text] [Related]
55. A new concept of drug delivery for acne.
Shroot B; Michel S; Allec J; Chatelus A; Wagner N
Dermatology; 1998; 196(1):165-70. PubMed ID: 9557255
[TBL] [Abstract][Full Text] [Related]
56. Adapalene 0.1% gel has low skin irritation potential even when applied immediately after washing.
Dunlap FE; Baker MD; Plott RT; Verschoore M
Br J Dermatol; 1998 Oct; 139 Suppl 52():23-5. PubMed ID: 9990417
[TBL] [Abstract][Full Text] [Related]
57. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
[TBL] [Abstract][Full Text] [Related]
58. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
[TBL] [Abstract][Full Text] [Related]
59. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
Pariser D; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
[TBL] [Abstract][Full Text] [Related]
60. Follicular penetration and distribution of topically applied CD 271, a new naphthoic acid derivative intended for topical acne treatment.
Jamoulle JC; Grandjean L; Lamaud E; Shroot B; Schaefer BH
J Invest Dermatol; 1990 May; 94(5):731-2. PubMed ID: 2139085
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
